Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
2024年2月16日 - 3:15AM
AllPennyStocks.com
Orphan drug designation, or ODD, is valuable on both a
humanitarian and a profitability basis. And this company is seeing
shares rally following news that it was granted the designation for
the...
To read the full story on AllPennyStocks.com, click
here.
Cardiol Therapeutics (NASDAQ:CRDL)
過去 株価チャート
から 4 2024 まで 5 2024
Cardiol Therapeutics (NASDAQ:CRDL)
過去 株価チャート
から 5 2023 まで 5 2024
